Clinical and Experimental Reproductive Medicine

  • 제34권1호
  • /
  • Pages.11-18
  • /
  • 2007
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지

보조생식술에 있어서 황체기 보강요법

Luteal Phase Support in Assisted Reproductive Technology

  • 김미란 (아주대학교 의과대학 산부인과학교실) ;
  • 황경주 (아주대학교 의과대학 산부인과학교실)
  • Kim, Mi-Ran (Department of Obstetrics and Gynecology, Ajou University School of Medicine) ;
  • Hwang, Kyung-Joo (Department of Obstetrics and Gynecology, Ajou University School of Medicine)
  • 발행 : 2007.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod 1999; 14: 107-11 https://doi.org/10.1093/humrep/14.1.11
  2. Pritts EA, Atwood AK. Luteal phase support in infertility treatment a meta-analysis of the randomized trials. Hum Reprod 2002; 17: 2287-99 https://doi.org/10.1093/humrep/17.9.2287
  3. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment a metaanalysis of randomized trials. Fertil Steril 1994; 61: 1068-76 https://doi.org/10.1016/S0015-0282(16)56758-2
  4. Toner JP. The luteal phase: luteal support protocols. In: Gardner DK, Weissman A, Howles CM, Shoham Z, editors. Textbook of assisted reproductive techniques. Kentucky: Martin Dunitz Ltd; 2001.p.515-26
  5. Paria BC, Lim H, Das SK. Molecular signaling in uterine receptivity for implantation. Semin Cell Dev Biol 2000; 11: 67-76 https://doi.org/10.1006/scdb.2000.0153
  6. Loumaye E. The control of endogenous secretion of LH by gonadotropin releasing hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer. Hum Reprod 1990; 5: 357-76 https://doi.org/10.1093/oxfordjournals.humrep.a137105
  7. Hughes EG, Federkow DM, Daya S, Sagle MA, Van De Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 2002; 58: 888-96
  8. Gomel V, Cheung PCK (eds). In Vitro Fertilization and Assisted Reproduction 1997 Monsuzzi Editore, Bologna. p.405-l5
  9. Edwards RG, Steptoe PC. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynecol 1980; 87: 737-56 https://doi.org/10.1111/j.1471-0528.1980.tb04610.x
  10. Smitz J, Erard P, Camus M. Pituitary gonadotropin secretory capacity during the luteal phase in superovulation using GnRH agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 1992; 7: 1225-9 https://doi.org/10.1093/oxfordjournals.humrep.a137831
  11. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta analysis of randomized trials. Fertil Steril 1994; 61: 1068-76 https://doi.org/10.1016/S0015-0282(16)56758-2
  12. Smitz J, Devroey P, Camus M. The luteal phase and early pregnancy after combined GnRH agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod 1988; 3: 585-90 https://doi.org/10.1093/oxfordjournals.humrep.a136750
  13. Lass A, Peat D, Avery S, Brinsden B. Histological evaluation of endometrium on the day of oocyte retrieval after gonadotropin releasing hormone agonist follicle stimulating hormone ovulation induction for in vitro fertilization. Hum Reprod 1998; 13: 3203-5 https://doi.org/10.1093/humrep/13.11.3203
  14. Balasch J, Jove I, Marquez M, Vanrell JA. Hormonal and histological evaluation of the luteal phase after combined GnRH agonist/gonadotropin treatment for superovulation in IVF or GIFT. Hum Reprod 1991; 6: 914-7 https://doi.org/10.1093/oxfordjournals.humrep.a137458
  15. Daya S. Efficacy of progesterone support in the luteal phase following in-vitro fertilization and embryo transfer: meta-analysis of clinical trials. Hum Reprod 1988; 3: 731-4 https://doi.org/10.1093/oxfordjournals.humrep.a136774
  16. Posaci C, Smitz J, Camus M, Osmanagaoglu K. Devroey P. Progesterone for the luteal support of assisted reproductive technologies; clinical options. Hum Reprod 2000; 15(SI): 129-48
  17. Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G, et al. Comparision of luteal phase profile in gonadotropin stimulated cycles with or without a gonadotropin-releasing hormone antagonist. Hum Reprod 2001; 16: 2258-62 https://doi.org/10.1093/humrep/16.11.2258
  18. Albano C, Grimbzis G, Smitz J, Reithmuller-Winzen H, Reissmann T, Van Steirteghem A, et al. The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin releasing hormone antagonist Cetrorelix. Fertil Steril 1998; 70: 357-9. https://doi.org/10.1016/S0015-0282(98)00135-6
  19. Tavaniotou A, Albano C, Smitz J, Devroey P. Comparison of LH concentrations in the early and midluteal phase in IVF cycles after treatment with hMG alone or in association with the GnRH antagonist Cetrorelix. Hum Reprod 2001; 16: 663-7 https://doi.org/10.1093/humrep/16.4.663
  20. Tavaniotou A, Albano C, Smitz J, Devroey P. Effect of climiphene citrate on follicular and luteal phase lutenizing hormone concentrations in in vitro cycles stimulated with gonadotropins and gonadotropinsreleasing hormone antagonist. Fertil Steril 2002; 77: 733-7 https://doi.org/10.1016/S0015-0282(01)03265-4
  21. Beckers NG, Macklon NS, Eijkemans MJC, Ludwig M, Felberbaum RE, Diedrich K, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, or gonadotropin-releasign hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88: 4186-92 https://doi.org/10.1210/jc.2002-021953
  22. MacDougall MJ, Tan SL, Jacobs HS. Invitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 597-600 https://doi.org/10.1093/oxfordjournals.humrep.a137702
  23. Hutchins-Williams KA, Dechemey AH, Lavy G, Diamond MP, Naftolin F, Lunenfeld B. Luteal rescue in in vitro fertilization-embryo transfer. Fertil Steril 1990; 53: 495-501 https://doi.org/10.1016/S0015-0282(16)53347-0
  24. Mochtar MR, Hogerzeil HV, Mol BW. Progesterone alone versus progesterone combined with hCG as luteal support in GnRHa/HMG induced IVF cycles; a randomized clinical triaL Hum Reprod 1996; 11: 1602-5 https://doi.org/10.1093/oxfordjournals.humrep.a019453
  25. Buvat J, Marcolin G, Guittard C, Herbaut JC, Dehaene JL. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over progesterone. Fertil Steril 1990; 53: 490-4 https://doi.org/10.1016/S0015-0282(16)53346-9
  26. Claman P, Domingo M, Leader A. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Hum Reprod 1992; 7: 487-9 https://doi.org/10.1093/oxfordjournals.humrep.a137676
  27. Araujo E, Bernardini L, Frederick JL, Asch RH, Balmaceda JP. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 1994; 11: 74-8 https://doi.org/10.1007/BF02215991
  28. Penzias AS. Luteal phase support. Fertil Steril 2002; 77: 318-23 https://doi.org/10.1016/S0015-0282(01)02961-2
  29. Simon JA, Robinson DW, Andrews MC, Hildebrand JR 3rd, Rocci ML Jr, Blake RE, et al. The absorption of oral micronized progesterone: the effect of food, dose proportionality and comparision with intramuscular progesterone. Fertil Steril 1993; 60: 26-33 https://doi.org/10.1016/S0015-0282(16)56031-2
  30. Unfer V, Casini ML, Costabile L, Gerli S, Baldini D, Di Renzo GC. 17 alpha-hydroxyprogesterone caproated versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. Reprod Biomed Online 2004; 9: 17-21 https://doi.org/10.1016/S1472-6483(10)62104-9
  31. Archer D, Fahy G, Viniegra-Sibal A, Snipes W, Foldesy RG. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am J Obstet Gynecol 1995; 173: 471-8 https://doi.org/10.1016/0002-9378(95)90268-6
  32. Tavaniotou A, Smitz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 2000; 6: 139-48 https://doi.org/10.1093/humupd/6.2.139
  33. Artini PG, Volpe A, Angioni S. A comparative randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995; 18: 51-6 https://doi.org/10.1007/BF03349699
  34. Chantilis SJ, Zeitoun KM, Patel SI. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril 1999; 72: 823-9 https://doi.org/10.1016/S0015-0282(99)00362-3
  35. Schoolcraft WB, Resla JS, Gee MJ. Experience with progesterone gel for luteal phase support in a highly successful IVF programme. Rum Reprod 2000; 15: 1284-8
  36. Abate A, Perino M, Abate FG. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer: a comparative study. Clin Exp Obstet Gynecol 1999; 16: 203-6
  37. Ludwig M, Schwartz P, Babahan B, Katalinic A, Weiss JM, Felberbaum R, et al. Luteal phase support using either Crinone or Utogest: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol 2002; 103: 48-52 https://doi.org/10.1016/S0301-2115(02)00010-6
  38. Stovall DW, Van Voorhis BJ, Mattignly KL, Sparks AF, Chapler FK, Syrop CH. The effectiveness of sublingual progesterone administration during cryopreserved embryo gransfer cycles: results of a matched follow-upstudy. Fertil Steril 1996; 65: 986 -91 https://doi.org/10.1016/S0015-0282(16)58274-0
  39. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Lewan D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2000; 73: 761-6 https://doi.org/10.1016/S0015-0282(99)00632-9
  40. Gorkemli H, Ak D, Akyurek C. Comparison of pregnancy outcomes of progesterone or progesterone p estradiol for luteal phase support in ICSI-ET cycles. Gynecol Obstet Invest 2004; 58: 140-4 https://doi.org/10.1159/000079115
  41. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta analysis of the randomized trials. Hum Reprod 2002; 17: 2287-99 https://doi.org/10.1093/humrep/17.9.2287
  42. Lewin A, Yanai N, Benhushan A. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertil Steril 1994; 62: 121-5 https://doi.org/10.1016/S0015-0282(16)56826-5
  43. Dawood MY. Corpus luteal insufficiency. Curr Opin Obstet Gynecol 1994; 6: 121-7
  44. Fritz MA, Hess DL, Patton PE. Influence of corpus luteum age on the steroidogenic response to exogenous human chorionic gonadotropin in normal cycling women. Am J Obstet Gynecol 1992; 167: 709-16 https://doi.org/10.1016/S0002-9378(11)91576-2
  45. Navot D, Laufer N, Kopolovic J, Rabinowitz R, Birkenfeld A, Lewin A, et al. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986; 314: 806-11
  46. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril 2001; 75: 1136-40 https://doi.org/10.1016/S0015-0282(01)01787-3
  47. Kleinstein J. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8$\%$) for luteal phase support during assisted reproduction. Fertil Steril 2005; 83: 1641-9 https://doi.org/10.1016/j.fertnstert.2004.11.073